ArticleJournal for immunotherapy of cancer2018

Efficacy of metformin in combination with immune checkpoint inhibitors (anti-PD-1/anti-CTLA-4) in metastatic malignant melanoma.

Muhammad Zubair Afzal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.